New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial-Reference-Cited by-同舟云学术

New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial

Published:2015-08 Issue:8 Volume:12 Page:1717-1725
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Padeletti Luigi,Pürerfellner Helmut,Mont Lluis,Tukkie Raymond,Manolis Antonis S.,Ricci Renato,Inama Giuseppe,Serra Paolo,Scheffer Mike G.,Martins Vitor,Warman Eduardo N.,Vimercati Marco,Grammatico Andrea,Boriani Giuseppe

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference25 articles.

1. 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2. Atrial fibrillation after DDDR pacemaker implantation;Gillis;J Cardiovasc Electrophysiol,2002

3. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care;Israel;J Am Coll Cardiol,2004

4. ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke;Healey;N Engl J Med,2012

5. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do not stop effective atrial-based antitachycardia pacing: Insights into episode duration and success rate for termination;HeartRhythm Case Reports;2024-08

2. Pacemaker-induced atrial fibrillation reconsidered—associations with different pacing sites and prevention approaches;Frontiers in Cardiovascular Medicine;2024-06-18

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

4. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

5. Reactive atrial-based anti-tachycardia pacing algorithm in cardiovascular implantable electronic devices is safe and feasible without increase in thromboembolic events in patients with a left atrial appendage closure device;International Journal of Arrhythmia;2023-10-01